STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
209.80
+7.95 (3.94%)
May 12, 2026, 12:57 PM EDT - Market open
STERIS Employees
STERIS had 17,787 employees as of March 31, 2025. The number of employees decreased by 392 or -2.16% compared to the previous year.
Employees
17,787
Change (1Y)
-392
Growth (1Y)
-2.16%
Revenue / Employee
$333,721
Profits / Employee
$43,982
Market Cap
20.58B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 17,787 | -392 | -2.16% |
| Mar 31, 2024 | 18,179 | 1,079 | 6.31% |
| Mar 31, 2023 | 17,100 | 678 | 4.13% |
| Mar 31, 2022 | 16,422 | 3,652 | 28.60% |
| Mar 31, 2021 | 12,770 | 411 | 3.33% |
| Mar 31, 2020 | 12,359 | 359 | 2.99% |
| Mar 31, 2019 | 12,000 | 0 | - |
| Mar 31, 2018 | 12,000 | 0 | - |
| Mar 31, 2017 | 12,000 | -2,000 | -14.29% |
| Mar 31, 2016 | 14,000 | 6,400 | 84.21% |
| Mar 31, 2015 | 7,600 | 1,600 | 26.67% |
| Mar 31, 2014 | 6,000 | 0 | - |
| Mar 31, 2013 | 6,000 | 1,000 | 20.00% |
| Mar 31, 2012 | 5,000 | 0 | - |
| Mar 31, 2011 | 5,000 | 0 | - |
| Mar 31, 2010 | 5,000 | 0 | - |
| Mar 31, 2009 | 5,000 | -300 | -5.66% |
| Mar 31, 2008 | 5,300 | 200 | 3.92% |
| Mar 31, 2007 | 5,100 | 0 | - |
| Mar 31, 2006 | 5,100 | -150 | -2.86% |
| Mar 31, 2005 | 5,250 | 150 | 2.94% |
| Mar 31, 2004 | 5,100 | 0 | - |
| Mar 31, 2003 | 5,100 | 604 | 13.43% |
| Mar 31, 2002 | 4,496 | -91 | -1.98% |
| Mar 31, 2001 | 4,587 | -223 | -4.64% |
| Mar 31, 2000 | 4,810 | 66 | 1.39% |
| Mar 31, 1999 | 4,744 | 244 | 5.42% |
| Mar 31, 1998 | 4,500 | 500 | 12.50% |
| Mar 31, 1997 | 4,000 | 3,440 | 614.29% |
| Mar 31, 1996 | 560 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 65,340 |
| GE HealthCare Technologies | 54,000 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Edwards Lifesciences | 16,000 |
| DexCom | 11,100 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
STE News
- 4 hours ago - STERIS Earnings Call Transcript: Q4 2026 - Transcripts
- 17 hours ago - Steris reports Q4 adjusted EPS $2.83, consensus $2.85 - TheFly
- 17 hours ago - Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08 - TheFly
- 18 hours ago - Steris forecasts 2027 profit above estimates, banks on procedure-driven demand - Reuters
- 20 hours ago - STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year - GlobeNewsWire
- 4 days ago - STERIS Appoints Pierre Boulud to Board of Directors - GlobeNewsWire
- 6 days ago - STERIS Announces Dividend of $0.63 per share - GlobeNewsWire
- 20 days ago - STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026 - GlobeNewsWire